Information supplied here is not intended to replace advice from your doctor. Our products are not intended to diagnose, treat, prevent or cure any disease
Cannabidiol is used as a therapy for several body conditions. Cannabidiol oil has been used by several groups globally with chronic pain, who collectively suggest that it can be effective. Some studies have also been carried out to ascertain it CBD can be used as a therapy for these conditions.
What is Cannabidiol Oil?
Also referred to as CBD oil, it is a product of the cannabis plant, and it is classified as a cannabinoid, a chemical that is found in marijuana and the hemp plants. The advantaged of using the cannabinoid is that it does not cause the highness felt when someone smokes marijuana. The use of CBD oil on patients with chronic pain attracted studies on how effective CBD therapy can help in fighting the chronic pain.
CBD Interacts with Brain Receptors for Pain Relief
Studies have shown that CBD is effective because it interacts with the brain receptors and the body immunity system. These receptors are the tiny proteins that are attached to the nerve cells that will receive the signalling in the form of chemicals sending these signals to the brain for interpretation.
Therefore when the CBD oil interacts with these cells as a therapy, it will provide signals to relieve the pain. Once these receptors receive these signals, they are sent to the brain, and the end result is a pain relief. What the scientists are busy with at the moment is unravelling how CBD interact specifically with these Cb1 & CB2 receptors.
Based on the research work that has been completed, it has been concluded that CBD has the potential to be an effective in pain management for some groups suffering chronic pain.
CLINICAL STUDY RESOURCES:
- Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain
- Cannabis, pain, and sleep: Sativex Clinical Trials
- Cannabinoids for neuropathic pain
- Neuropathic orofacial pain: Cannabinoids as a therapeutic avenue
- The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain
- Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation
- Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy
- Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain
- Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action
- CBD Is a Potential Therapeutic for the Affective-Motivational Dimension of Incision Pain in Rats